Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Silco Pharmaceuticals Revenue

Silco Pharmaceuticals had revenue of 108.87M BDT in the quarter ending March 31, 2025, with 3.80% growth. This brings the company's revenue in the last twelve months to 428.63M, down -1.71% year-over-year. In the fiscal year ending June 30, 2024, Silco Pharmaceuticals had annual revenue of 410.10M, down -11.75%.

• Revenue (ttm): 428.63M
• Revenue Growth: -1.71%
• P/S Ratio: 3.29
• Revenue / Employee: 1.37M
• Employees: 313
• Market Cap: 1.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	410.10M	-54.59M	-11.75%
Jun 30, 2023	464.70M	-94.77M	-16.94%
Jun 30, 2022	559.47M	-41.59M	-6.92%
Jun 30, 2021	601.06M	-132.59M	-18.07%
Jun 30, 2020	733.65M	-185.39M	-20.17%